Apoptosis as the basic mechanism of cytotoxic action of ursolic and pomolic acids in glioma cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Pentacyclic triterpene acids are of great interest as compounds that exhibit selective cytotoxicity against malignant tumor cells. If earlier studies were carried out mainly in cancer cells of epithelial origin, in the present work the cytotoxic effect of ursolic and pomolic acids on the primary and permanent glioma cell lines was analyzed. Both compounds are toxic to oncotransformed cells and induce apoptosis in U-87 MG line. Using molecular docking, it has been shown that Akt1 and MDM2 may be potential targets of the studied triterpene acids. It has been suggested that ursolic and pomolic acids induce apoptosis in glioma cells through inhibition of the PI3K/Akt signaling pathway, and they can be considered as potentially promising agents for the treatment of glioblastoma.

About the authors

T. S. Frolova

Vorozhtsov Novosibirsk Institute of Organic Chemistry; Institute of Cytology and Genetics; Novosibirsk State University

Author for correspondence.
Email: frolova@nioch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090; Novosibirsk, 630090

A. V. Lipeeva

Vorozhtsov Novosibirsk Institute of Organic Chemistry

Email: frolova@nioch.nsc.ru
Russian Federation, Novosibirsk, 630090

D. S. Baev

Vorozhtsov Novosibirsk Institute of Organic Chemistry; Novosibirsk State University

Email: frolova@nioch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090

Y. A. Tsepilov

Institute of Cytology and Genetics; Novosibirsk State University

Email: frolova@nioch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090

O. I. Sinitsyna

Institute of Cytology and Genetics; Novosibirsk State University

Email: frolova@nioch.nsc.ru
Russian Federation, Novosibirsk, 630090; Novosibirsk, 630090

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pleiades Publishing, Inc.